Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hartung

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer SocietyG Hartung, G Stehle, H Sinn, et al.
Onkologie|June 4, 2005
Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III studyG Hartung, R-D Hofheinz, Y Dencausse, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIVL Bergmann, L Maute, G Heil, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2015
A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastomaManfred Westphal, Oliver Heese, Joachim P Steinbach, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer SocietyG Hartung, G Stehle, H Sinn, et al.
Onkologie|June 4, 2005
Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III studyG Hartung, R-D Hofheinz, Y Dencausse, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIVL Bergmann, L Maute, G Heil, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2015
A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastomaManfred Westphal, Oliver Heese, Joachim P Steinbach, et al.
Pageof 5